07/26/2024
8:45 PM | Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Issuer)
Slingsby Brian Taylor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:50 PM | Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2024
5:34 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:41 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:36 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
3:37 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
3:39 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
07/11/2024
3:51 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2024
3:53 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024
4:44 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:21 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
3:39 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
4:14 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
3:33 PM | Gold Alexander M (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:31 PM | Gold Alexander M (Reporting)
Mineralys Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/14/2024
5:15 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:56 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
7:06 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
4:32 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:33 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:51 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
4:56 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
3:50 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
5:51 PM | Kolchinsky Peter (Reporting)
Mineralys Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:38 PM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
3:43 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:14 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
6:07 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:10 AM | Mineralys Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/15/2024
3:24 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
11:15 PM | Mineralys Therapeutics (Filer)
| Form EFFECT | |
04/11/2024
3:35 PM | Mineralys Therapeutics (Filer)
| Form 424B5 | |
04/09/2024
6:15 AM | Mineralys Therapeutics (Filer)
| Form DEF 14A | |
04/09/2024
6:18 AM | Mineralys Therapeutics (Filer)
| Form DEFA14A | |
04/09/2024
6:21 AM | Mineralys Therapeutics (Filer)
| Form ARS | |
04/04/2024
7:04 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
3:44 PM | Mineralys Therapeutics (Filer)
| Form S-3/A | |
03/21/2024
6:43 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
6:30 AM | Mineralys Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/21/2024
6:14 AM | Mineralys Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2024
4:35 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |
02/15/2024
3:20 PM | Mineralys Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
02/14/2024
8:06 PM | Mineralys Therapeutics (Issuer)
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:07 PM | AKKARAJU SRINIVAS (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:49 PM | Kolchinsky Peter (Reporting)
Mineralys Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:04 AM | ADAMS STREET PARTNERS LLC (Filed by)
Mineralys Therapeutics (Subject)
| Form SC 13G | |
02/08/2024
3:41 PM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/12/2024
3:01 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
8:04 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2023
5:18 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
7:20 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
4:15 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
9:06 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
3:11 PM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
3:13 PM | Mineralys Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
3:13 PM | Mineralys Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
3:13 PM | Karydas Daphne (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
3:14 PM | Karydas Daphne (Reporting)
Mineralys Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/08/2023
7:49 AM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2023
6:11 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2023
6:11 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2023
3:55 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/10/2023
5:51 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
